MedTrace Logo

A Disease Registry of Patients With Mantle Cell Lymphoma

NCT03816683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2025-11-14

No results posted yet for this study

Summary

The purpose of this study is to create a patient registry in order to assess treatment patterns, physician reported clinical outcomes and patient-reported health-related quality of life among patients diagnosed with Mantle Cell Lymphoma (MCL) who newly initiated a novel therapy in the past 6 months and whose treatment is ongoing at the time of enrollment.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Richard Hermann · Senior Medical Director, Haematology

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2024-03-18
Completion
2024-03-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03816683 on ClinicalTrials.gov